MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

NASDAQ:MLTX

Overview | Financials
Company Name MoonLake Immunotherapeutics
Symbol MLTX
Currency USD
Price 48.83
Market Cap 3,099,450,069
Dividend Yield 0%
52-week-range 31.42 - 58.26
Industry Biotechnology
Sector Healthcare
CEO Dr. Jorge Santos da Silva
Website https://www.moonlaketx.com

An error occurred while fetching data.

About MoonLake Immunotherapeutics

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021

Related Stocks

Marinus Pharmaceuticals, Inc. logo

Marinus Pharmaceuticals, Inc.

MRNS

0.55 USD

Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc.

PLRX

1.61 USD

DermTech, Inc. logo

DermTech, Inc.

DMTK

0.094 USD

Immunic, Inc. logo

Immunic, Inc.

IMUX

0.773 USD

Kronos Bio, Inc. logo

Kronos Bio, Inc.

KRON

0.87 USD

Personalis, Inc. logo

Personalis, Inc.

PSNL

5.06 USD

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

28.88 USD

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRA

25.33 USD

Tactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc.

TCMD

10.11 USD

Financials

Numbers are in millions USD

Numbers are in millions USD